• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症免疫治疗的树突状细胞

[Dendritic cells for cancer immunotherapy].

作者信息

Kakimi Kazuhiro, Kondo Atsushi, Matsushita Hirokazu

机构信息

Department of Immunotherapeutics, The University of Tokyo Hospital.

出版信息

Nihon Rinsho. 2012 Dec;70(12):2130-5.

PMID:23259385
Abstract

Dendritic cells (DC) are the antigen presenting cells that initiate and regulate immunity. There are distinct DC subsets with specialized functions spread throughout the body. The type of immune response is determined by the DC subsets involved. Therefore, it is important to understand distinct phenotype and functions of these DC subsets in terms of antigen uptake and processing for MHC class I- and II-restricted presentation and receptors for foreign and endogenous signals. These insights facilitate the direct targeting of antigens to DC surface receptors in vivo rather than ex vivo culturing DC and antigen loading. In addition, novel DC immunotherapies will be in combination with drugs targeting immunological check points.

摘要

树突状细胞(DC)是启动和调节免疫的抗原呈递细胞。在全身分布着具有特殊功能的不同DC亚群。免疫反应的类型由所涉及的DC亚群决定。因此,了解这些DC亚群在MHC I类和II类限制性呈递的抗原摄取和加工以及外来和内源性信号受体方面的不同表型和功能非常重要。这些见解有助于在体内将抗原直接靶向DC表面受体,而不是在体外培养DC并加载抗原。此外,新型DC免疫疗法将与靶向免疫检查点的药物联合使用。

相似文献

1
[Dendritic cells for cancer immunotherapy].用于癌症免疫治疗的树突状细胞
Nihon Rinsho. 2012 Dec;70(12):2130-5.
2
Harnessing dendritic cells for immunotherapy.利用树突状细胞进行免疫治疗。
Semin Immunol. 2011 Feb;23(1):2-11. doi: 10.1016/j.smim.2011.02.001. Epub 2011 Mar 5.
3
Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.树突状细胞类型,即哺乳动物胸腺微环境中的辅助细胞。树突状神经-内分泌-免疫细胞网络中的抗原呈递。
In Vivo. 1997 Jul-Aug;11(4):351-70.
4
Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.树突状细胞免疫疗法:从体外负载到体内靶向
Nat Rev Immunol. 2007 Oct;7(10):790-802. doi: 10.1038/nri2173.
5
Targeted antigen delivery and activation of dendritic cells in vivo: steps towards cost effective vaccines.靶向抗原递呈和树突状细胞体内激活:迈向具有成本效益疫苗的步骤。
Semin Immunol. 2011 Feb;23(1):12-20. doi: 10.1016/j.smim.2011.01.001. Epub 2011 Jan 26.
6
Dendritic cell immunobiology and potential roles in immunotherapy.树突状细胞免疫生物学及其在免疫治疗中的潜在作用。
Malays J Pathol. 2007 Jun;29(1):1-18.
7
Current issues in dendritic cell cancer immunotherapy.树突状细胞癌症免疫疗法的当前问题
Curr Opin Mol Ther. 2002 Feb;4(1):54-63.
8
Dendritic cell-based cancer immunotherapies.基于树突状细胞的癌症免疫疗法。
Arch Immunol Ther Exp (Warsz). 2009 May-Jun;57(3):189-98. doi: 10.1007/s00005-009-0025-x. Epub 2009 May 29.
9
Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo.树突状细胞亚群在体内的固有和协同抗原呈递功能。
Nat Rev Immunol. 2007 Jul;7(7):543-55. doi: 10.1038/nri2103.
10
Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.将糖基化修饰的卵清蛋白靶向小鼠树突状细胞特异性细胞间黏附分子-3抓取非整合素(DC-SIGN)转基因树突状细胞可增强MHC I类和II类分子的呈递。
Mol Immunol. 2009 Dec;47(2-3):164-74. doi: 10.1016/j.molimm.2009.09.026. Epub 2009 Oct 8.